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Latent variable models for gene–
environment interactions in longitudinal
studies with multiple correlated exposures
Yebin Tao,*† Brisa N. Sánchez and Bhramar Mukherjee
Many existing cohort studies designed to investigate health effects of environmental exposures also collect data on
genetic markers. The Early Life Exposures in Mexico to Environmental Toxicants project, for instance, has been
genotyping single nucleotide polymorphisms on candidate genes involved in mental and nutrient metabolism and
also in potentially shared metabolic pathways with the environmental exposures. Given the longitudinal nature
of these cohort studies, rich exposure and outcome data are available to address novel questions regarding gene–
environment interaction (G×E). Latent variable (LV) models have been effectively used for dimension reduction,
helping with multiple testing and multicollinearity issues in the presence of correlated multivariate exposures
and outcomes. In this paper, we first propose a modeling strategy, based on LV models, to examine the associa-
tion between repeated outcome measures (e.g., child weight) and a set of correlated exposure biomarkers (e.g.,
prenatal lead exposure). We then construct novel tests for G × E effects within the LV framework to examine
effect modification of outcome–exposure association by genetic factors (e.g., the hemochromatosis gene). We con-
sider two scenarios: one allowing dependence of the LV models on genes and the other assuming independence
between the LVmodels and genes. We combine the two sets of estimates by shrinkage estimation to trade off bias
and efficiency in a data-adaptive way. Using simulations, we evaluate the properties of the shrinkage estimates,
and in particular, we demonstrate the need for this data-adaptive shrinkage given repeated outcome measures,
exposure measures possibly repeated and time-varying gene–environment association. Copyright © 2014 John
Wiley & Sons, Ltd.
Keywords: gene–environment dependence; gene–environment interaction; growth curves; latent variable
model; shrinkage estimation
1. Introduction
Most common human diseases have a multifactorial etiology involving genetic factors (G) and envi-
ronmental exposures (E). In recent years, many environmental cohort studies initially designed to study
environmental health effects have begun to collect genetic information on study participants. One of the
initial goals of the Early Life Exposure in Mexico to Environmental Toxicants (ELEMENT) project, for
example, was to assess the impact of lead exposure on children’s mental development. However, the ELE-
MENT project, now of more than 18 years duration, has expanded to include longitudinal outcomes such
as anthropometry, adolescent behavior, sexual maturation, and cardiovascular health among youth [1–3].
Given the solid grounding in environmental health, measures of multiple toxicants, particularly lead, are
available, and some have been measured repeatedly over time.With the lowering cost of genotyping tech-
nologies, the study has begun to genotype stored biological samples for single nucleotide polymorphisms
(SNPs) along genes known to be involved in mental or nutrient metabolism [4–8]. It is now possible to
interrogate the available ELEMENT data to help elucidate questions regarding how genetic makeup may
exacerbate or reduce exposure effects previously identified, that is, examine gene–environment interac-
tion (G×E) [9–12]. Meanwhile, given known challenges to conductG×E studies primarily due to sample
size limitations [13], there is an increasing need for methods and modeling strategies that can exploit the
complex data structure in an efficient and simultaneously robust way.
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In this manuscript, we develop modeling strategies to examine the joint impact of genes and multi-
ple exposure measures on health outcomes measured repeatedly over time. To motivate and illustrate
the ideas, we focus on four biomarkers of prenatal lead exposure (maternal bone lead concentrations
at two sites and maternal and umbilical cord blood lead concentrations), two SNPs on the hemochro-
matosis (HFE) gene, and weight measured approximately every 6 months from birth to age of 4. Given
that weight is measured at multiple time points approximately balanced across participants, one possible
simple analysis is to look at each pair of (G,E) at a given time point by running several cross-sectional
analyses using multiple linear regression. This naı¨ve method lacks power due to the cost of multiple test-
ing. One could alternatively use standard mixed models or generalized estimating equations to account
for the complete longitudinal trajectory of outcome in one model, but again look at each pair of (G,E)
separately. With a SNPs and b exposures, this will lead to a×b different models. By reducing the dimen-
sion of G,E, and Y , one can decrease the number of tests and models to be fit. With a correlated set of
exposure biomarkers, measures of lead in our example, the use of latent variables (LVs) is a natural way
to reduce the dimension of the exposure space. Very few papers in the literature contain examples of a
multi-G-multi-E analysis in a joint multivariate-Y model.
Longitudinal studies offer more precise characterization of cumulative lifetime exposure and within-
person variability than a cross-sectional or case-control study [14, 15]. However, they require careful
analytic considerations as the interplay of genes and environment may change dynamically over time.
That is, the effect modification role of genetic factors may become increasingly important, or their initial
protective role may fade over time. In spite of the vast literature on statistical methods for analyzing
G × E effects in case-control studies [16, 17], efficient alternative modeling strategies for G × E effects
in longitudinal studies have received very little attention [18].
Latent variable models have been widely used in modeling longitudinal and multi-level data [19, 20].
They have also been applied in environmental health studies to characterize the health effects of a set of
environmental exposures that are highly correlated, thus avoiding the multiple testing issue when dealing
with each exposure individually [21, 22]. These models have great potential in testing G × E effects in
the context of multiple genes and multiple correlated environmental exposures.
Currently, only a few studies have attempted LV models for studying G × E effects in cross-sectional
or cohort studies [23–26]. As a recent contribution to this area, Sánchez et al. [26] investigated G × E
effects for univariate outcome with multiple correlated exposures in a cross-sectional study. They built
LV models for the exposures to deal with the exposure measurement errors and boost efficiency for
testing G × E effects by reducing the number of tests and combining information across the available
biomarkers. One important contribution of their paper was to allow for a separate gene–environment
(G-E) dependence model that may help understand how exposures are related to genes (especially when
the genes are chosen based on the metabolic pathway for the environmental exposures). To improve
efficiency and protect against bias, the authors used shrinkage estimation for various specifications of the
G-E association model [27–29]. Their proposed approach yielded estimates that balanced between bias
and variance and provided an automated way to avoid model selection issues because a robust adaptive
estimator was recommended as the default choice.
However, a general LV framework for studying G×E effects on longitudinal or multivariate outcomes
has not been proposed. In this paper, we undertake the task of integrating longitudinally measured out-
come, a set of correlated exposures (potentially time-varying), and genes (time-invariant genotype data
measured at SNPs), as an extension to the cross-sectional framework of Sánchez et al. [26]. Several new
and challenging enhancements are warranted. First, we propose to use LV models for both exposures
and the longitudinal outcome. We model the weight trajectories using random coefficients correspond-
ing to parametric functions of time that are chosen a priori; the use of random coefficients naturally fits
into the general LV modeling framework [20]. Figure 1 is a path diagram describing the relationships
between exposures biomarkers (E), latent exposures (U), genes (G), latent outcome (B), and observed
longitudinal health outcome (Y). The diagram encodes the time-independent G × U term (interaction
arrow directed at the random intercept B0), as well as the three-way G × U × T term of interest (dashed
arrow directed at the latent outcome Bk). Second, in addition to combining estimates from models that
assume varying degrees of G-E dependence [26], we also consider varying degrees of dependence of
the variance of the longitudinal outcome on the genetic factors, denoted as G-b heteroscedasticity. The
third and main novelty is to consider time-varying G×E effects. This time-dependent interaction may be
captured by a linear three-way interaction term G × U × T or by a more complex non-linear function of
time. We additionally examine how adaptive shrinkage estimation can be used to gain power for detect-
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Figure 1. Path diagram showing relationships among exposure biomarkers (E), latent exposures (U), genes (G),
longitudinal health outcome (Y), and latent outcome (B). The unspecified arrows indicate the possible effects of
covariates and random errors.
ing this time-dependent interaction when the gene–environment association structure can vary over time.
Previous work in adaptive shrinkage in longitudinal studies is limited.
We organize the rest of this paper as follows: in Section 2, we present the LV models for both a set
of correlated exposures and the longitudinal outcome including gene–environment interactions. We also
incorporate varying degrees ofG-E andG-b heteroscedasticity into our modeling framework and present
shrinkage estimation to adaptively compromise between themost parsimonious andmost flexible models.
In Section 3, we present a more general LV model where the exposures may vary over time. Analyses
of the ELEMENT data (Section 4) and simulation studies (Section 5) bring out salient features of our
modeling and G × E testing strategy. Section 6 briefly discusses the advantages and limitations of our
methodology and indicates possibilities for further extensions.
2. Latent variable models for G × E studies with longitudinal outcome
2.1. Model formulation
Let Yij denote the health outcome for subject i (i = 1,… ,N) at time tij ( j = 1,… , ni). Let Ui be an m× 1
vector of latent exposures underlying the observed exposure measurements Ei (p × 1, p > m). In our
motivating example, m = 1, p = 4, and U represent prenatal lead exposure as reflected by the four lead
biomarkers collected in several tissues. In other applications, variables in E may represent metabolites
of a parent compound U [30], and one can propose more than one U (m > 1) if more than one family
of exposure biomarkers are observed (e.g., mercury and polychlorinated biphenyls) [31], or if exposures
are observed repeatedly over time [32]. Genetic subgroups are denoted by a categorical variable Gi. For
brevity, we consider only binary Gi: for example given multiple risk alleles, this may be zero for wild
type and one for at least one variant. To deal with more categories (e.g., quantiles of a polygenic risk
score [33]), we can simply use multiple dummy variables. Our LVmodels contain two parts: the exposure
model and the outcome model.
The exposure model consists of a measurement model relating the observed exposure measurements
Ei to the LVs Ui
Ei = 𝜈0 + 𝜈1Gi + Λ0Ui + Λ1Gi ⋅ Ui + 𝛿i (1)
and an accompanying model with covariates Vi (q × 1) that may be related to the LVs Ui
Ui = 𝛼0 + 𝛼1Gi + 𝛼VVi + 𝜍i (2)
Mean vectors 𝜈 and 𝜈1 are p× 1, whereas factor loadings matrices Λ and Λ1 are p×m (see identifiability
constraints in the succeeding text). Note that (1) allows the intercepts and factor loadings to differ by
genetic subgroups. The error vector 𝛿i has zero mean and covariance matrix ΘG (p × p) that may also
depend on genetic subgroups. The hypotheses of Λ1 = 0, 𝜈1 = 0, and ΘG = Θ could be tested using
Copyright © 2014 John Wiley & Sons, Ltd. Statist. Med. 2015, 34 1227–1241
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standard procedures [34, 35], which may have low power, but we avoid this model selection step by
shrinkage estimation (see Section 2.2 for details). Regression coefficients 𝛼0 and 𝛼1 are m × 1, and 𝛼V is
m× q. The error vector 𝜍i has mean zero and covariance matrix ΦG(m×m). In (1) and (2), 𝜈1, Λ1, and 𝛼1
characterize the G-E association. We present the exposure model with coefficients independent of time,
which is usually the case when we have time-invariant exposures (e.g., prenatal lead exposures). We also
propose an extension of this model to time-varying exposures in Section 3.
The outcome model follows the latent growth curve modeling approach [20, 36, 37]. The longitudinal
trajectory is modeled by
Yij = B0i +
∑
k
Bki fk(tij) + 𝜀ij, (3)
where B0i is the subject-specific intercept (e.g., birth weight for subject i) and Bki is the subject-specific
slope corresponding to a known functional predictor term fk(t) (e.g., t, t2 or t−1, k = X1,… ,K), which cap-
tures nonlinearity in the trajectories, and between-subject variation in the growth curves. We can choose
fk’s from a known set of parametric functions using model selection criteria (e.g., Bayesian information
criteria) [37], prior to incorporating genes and exposures into the model.We assume that 𝜀ij’s are indepen-
dently distributed with mean zero and variance 𝜎2 (under a balanced design, the variance can be allowed
to vary over time if necessary). The latent outcomes B0i and Bki explain the correlation between Yij’s. We
then associate B0i or B0i and Bki with Ui and Gi conditional on a set of baseline covariates/confounders
Zi via the following models:




G×U,0Gi ⋅ Ui + 𝛽
′
Z,0Zi + b0i, (4)




G×U,kGi ⋅ Ui + 𝛽
′
Z,kZi + bki. (5)
The random effects b0i and bki have a joint normal distribution with mean zero and variance DG, again
allowed to vary across genetic subgroups. By plugging (4) and (5) into (3), one can see that parameter vec-
tors 𝛽G×U,0 and 𝛽G×U,k characterize the G×E effects at baseline and subsequent time points, respectively.
To model the latent outcomes Bk in (5) as fixed effects, we constrain the variance of its corresponding
bk to be zero; the variance of B0 will generally not be zero given the correlations among the repeated
outcome measures. Although in the general notation of (5), we have allowed all baseline covariates Zi
to be associated with Bki; in practice, this may have to be restricted by certain assumptions, either from
the perspective of estimating a potentially large number of parameters 𝛽Z,k or through a priori knowledge
that may rule out the effect of certain covariates on Bki. Such constraints can be readily imposed by fixing
subsets of 𝛽Z,k to be zero. Finally, if time-varying covariates are available, they can be added directly to
(3) as fixed effects.
In summary, (1) and (2) denote the relationships among observed and latent exposures and their
relationships to covariates, and (3)–(5) link observed outcomes to latent growth outcomes, and latent
outcomes to latent exposures, genes, and covariates. The parameters in (1)–(5) and their meanings are
listed in Table I.
Overall G × E model
Models (1)–(5) are presented as general models for G × E analysis, allowing for time-varying G × E
effects. In practice, we might first explore whether there is an overall G × E effect marginalized over
time, that is, to test H0: 𝛽G×U,0 = 0 in (4) while forcing 𝛽G×U,k in (5) to be zero. We refer to this model
as the ‘overall G × E model’. In reference to Figure 1, the overall G × E model describes the structural
relationship between G, U, and B0 while removing the dashed line representing G × E × T effects.
G × E × T model
To examine whether theG×E effects vary over time, we can testH0: 𝛽G×U,k = 0 for all k = 1,… ,K in (5).
We call the model that estimates 𝛽G×U,k the ‘G×E × T model’, which corresponds to the presence of the
dashed line in Figure 1. However, because fk’s are chosen principally to model the trajectory of the health
outcome, they may not fully capture the true functional form of the temporal variation in G × E effects.
To gain a better idea of this functional form, we may resort to prior literature or exploratory methods. For
example, if the outcome is measured at several fixed time points (e.g., yearly weight) and sample size is
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Table I. Summary of parameters in models (1) to (5).
Model/parameter* Interpretation
Model (1) Measurement model relating observed exposure measurements and latent
exposures
𝜈0 (p × 1) Intercepts of exposure measurements for the genetic reference subgroup
𝛎𝟏 (p × 1) Difference in intercepts of exposure measurements between genetic subgroups
Λ0 (p × m) Factor loadings for the genetic reference subgroup
𝚲𝟏 (p × m) Difference in factor loadings between genetic subgroups
𝚯𝐆 (p × p) Covariance matrix for error vector 𝛿, dependent on genetic subgroup G
Model (2) Model for latent exposure given covariates
𝛼0 (m × 1) Intercepts of latent exposure for the genetic reference subgroup
𝜶𝟏 (m × 1) Difference in intercepts of latent exposure between genetic subgroups
𝛼V (m × q) Association between latent exposure and covariates V
𝚽𝐆(m × m) Covariance matrix for error vector 𝜍, dependent on genetic subgroup G
Model (3) Model for observed outcome measurements given latent outcomes
B0i Subject-specific intercept for the health trajectory
Bki Subject-specific slope for the health trajectory
𝜎2 Variance of residual error 𝜀
Model (4)/(5) Structural model linking latent exposures to latent outcomes
𝛽0,∙ Mean intercept/slope for the health trajectory in the genetic reference
subgroup
𝜷𝟏,∙ Difference in mean intercept/slope for the health trajectory between genetic subgroups
𝛽U,∙ Association between latent outcomes and latent exposures for the genetic
reference subgroup
𝜷𝐆×𝐔,∙ Difference between genetic groups in the association between latent outcomes
and latent exposures
𝛽Z,∙ Association between latent outcomes and covariates Z
𝐃𝐆 Covariance matrix for random effects b0 and bk, dependent on genetic subgroup
(K + 1) × (K + 1) G
*Parameters charactering dependence on genetic subgroups are in bold; vectors and matrices have
dimension listed.
adequate, we may model the G×E effect on the outcome at each distinct time point separately (i.e., time
treated as dummy variables).We then plot theG×E coefficients against time in ameta-regression analysis
to gauge a suitable functional form of time-varying interaction. We may need to include a function of
time, not necessarily a subset of the fk’s, to be incorporated into (5) to better model the G × E × T effect.
We use our data example to illustrate such exploratory strategies.
Identifiability
To make the LV models identifiable, we put standard constraints on the model parameters [22, 38]. For
instance, typical constraints involve having factor loading matrices be prespecified as block diagonal,
which means that a given observed exposure reflects only one LV, letting the first element of each nonzero
block be one, and fixing the first element of the intercepts to be zero. These constraints fix the mean
and scale of the LV, which are otherwise not identifiable. We apply these types of constraints to the
measurement model (1). Specifically, we constrain the first entries of each block of Λ0 to be one and the
corresponding entries of 𝜈0 to zero so that the mean and scale of the LVs in the reference genetic subgroup
are identifiable. However, as G appears also in (2), more constraints are needed. We additionally fix the
first entries of the corresponding blocks of Λ1 to be zero such that the units of the LV are the same in
both groups; this ensures identifiability of the variance of the LV among the genetic reference subgroup,
Copyright © 2014 John Wiley & Sons, Ltd. Statist. Med. 2015, 34 1227–1241
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ΦG=0 in (2). Similarly, we constrain the corresponding entries of 𝜈1 to be zero such that the difference in
means of the latent exposures between the genetic subgroups (i.e., 𝛼1 in (2)) is identifiable. For instance,
in the context of prenatal lead exposure (Section 4), the factor loading corresponding to patella lead inΛ0
is set to 1 and the difference in the factor loading for patella lead between the genetic subgroups, element
in Λ1, corresponding to patella lead is zero so that the units of the LV are in the units of patella lead
concentration (μgPb/g) in both groups. We also assume that the off-diagonal elements of ΘG are zero,
reflecting conditional independence between Ei’s given Ui. Note that this conditional independence is
not strictly required and can be relaxed given strong a priori knowledge (e.g., use of the same laboratory
or other circumstances that may give rise to additional correlation among Ei’s). If sample size is small,
we can consider additional constraints to reduce the number of parameters to be estimated, for example,
forcing the elements of ΘG to be identical across genetic subgroups, that is, ΘG=0 = ΘG=1.
2.2. Likelihood and estimation






and 𝜃 be the vector of all model parameters. Assuming normality for all residuals, and
integrating over the LV, the joint marginal distribution of the observed outcomes and exposures for sub-
ject i has a multivariate normal density f (Oi|Gi, ti,Vi,Zi; 𝜃) (see Supplementary Materials, Likelihood,
for details). The log likelihood of 𝜃 is then, l(𝜃) =
∑N
i=1 log f (Oi|Gi, ti,Vi,Zi; 𝜃). We apply the stan-
dard maximum likelihood estimation (MLE) to our LV models, using the R package lavaan by Rosseel
(2012) (http://lavaan.org) [39]. The parameter estimates are obtained by maximizing l(𝜃). Variances for
parameters can be obtained by inverting the information matrix I(𝜃) = −E(𝜕2l(𝜃)∕𝜕𝜃𝜕𝜃′ ). The codes for
implementing the methods are available at http://www-personal.umich.edu/∼brisa/.
G-E dependence and G-b heteroscedasticity
Our LV models for exposures and longitudinal outcome are presented in a general way, allowing for full
dependence on the genetic factors. To reduce the dimensionality of the parameter space, we may impose
a certain degree of G-E independence as well as G-b homoscedasticity. These assumptions may hold for
external exposures (air pollution and heavy metals) and a set of genes unrelated to the exposure but may
not be so plausible for behavioral exposures/outcomes and genes in the same metabolic pathway. The
assumption of G-E independence and G-b homoscedasticity can potentially boost the power of tests for
interaction. However, the estimates of interaction may be seriously biased when the underlying assump-
tion is violated [27, 40]. In our study, the mean and variance of the subject’s birth weight and rate of
weight gain, as well as the prenatal lead exposure, may not all be independent of genetic factors. The HFE
gene shares a common metabolic pathway with lead exposure [41] and may potentially induce higher
variance in the outcomes. The G-b heteroscedasticity has not been previously discussed in the literature,
but we consider it possible, because groups defined by G could influence not only the outcome mean
but also its variance, and furthermore, misspecifying outcome variance when latent predictors are in the
model could lead to substantial bias in the regression coefficients [32].
It is difficult to determine the plausibility of the G-E dependence and G-b heteroscedasticity based
on current data. A convenient and automated way is to model varying degrees of dependence and use
shrinkage to obtain an estimator that balances bias and efficiency. In our study, we will first build the
model under the most restrictive assumption that all the parameters are homogeneous across genotypes.
We use ‘AI’ to denote the assumption of G-E independence and G-b homoscedasticity
AI ∶ (𝜈1,Λ1,ΘG, 𝛼1,ΦG,DG) = (0, 0,Θ, 0,Φ,D)
In the second step, we relax all the constraints and build themodel under the assumption of completeG-
E dependence andG-b heteroscedasticity, denoted as ‘AD’. We consider the possibility that the variances
of the latent outcomes also depend on gene, that is, all parameters may vary across genetic subgroups.
Clearly, the AD model has many more parameters than the AI model. The AI model may improve
efficiency for interaction estimates but could introduce bias if the assumed independence constraints are
incorrect. On the other hand, the problem with the AD model is that larger sample sizes are needed to
have precise estimates of the parameters of interest. If the sample size is modest, we may put constraints
on parameters like ΘG. After estimating AI and AD, it is not straightforward to assess relative model
fits for these two models. For instance, a simple two-stage approach of first testing the plausibility of
parameter constraints using current data and then proceeding with AI or ADwill incur a high Type-I error
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rate, because the study is likely underpowered to detect significant differences across genetic subgroups
for all parameters. Adaptive shrinkage of the robust AD estimators to efficient AI estimators appears to
be an attractive alternative.
Shrinkage estimation
We use shrinkage estimation to combine MLE estimates under assumptions of AI and AD following
Chen et al. [29]. Denoting the two estimators by ?̂?AIand ?̂?AD, we define





as the shrinkage estimator (SK). Themultivariate shrinkage (MV)weights areKMV = V̂(V̂+?̂??̂?T )−1 with
?̂? = ?̂?AI − ?̂?AD. V̂ is the estimated asymptotic variance matrix of the estimated difference ?̂? . Note that (6)
is only defined for common parameters in the two models, and KMV is an s× smatrix (s is the dimension
of ?̂?AI). An alternative way to obtain shrinkage weights is to calculate them separately for each parameter
so that we only need to deal with parameters of primary interest. This is called ‘component-wise (CW)’





(l = 1,… , s) [29]. Because the SK depends on two correlated estimators ?̂?AD and
?̂?AI , its variance is approximated using the multivariate delta method [26, 29]. In a given data analysis,
the variance can also be straightforwardly obtained via bootstrap.
To understand how the SK works, we need to carefully examine the weights. As we know, ?̂?AD is
unbiased but may not be efficient due to the large number of parameters in the model. This is particularly
a problem if the sample size is modest. ?̂?AI , on the other hand, is usually efficient but can be seriously
biased if AI is violated. When the bias is large, the weight KCWl goes toward zero, and one would favor
?̂?AD. Otherwise, one will favor the more efficient ?̂?AI . This is a typical bias-variance tradeoff [28]. The
CW shrinkage tends to have better efficiency than the MV shrinkage, because KMV uses the full matrix
V̂ and large sampling errors in the off-diagonals of V̂ outweighs the potential efficiency gain from MV
shrinkage [29]. Sánchez et al. [26] has shown that in the cross-sectional setting, the MV shrinkage has
larger mean squared error (MSE) despite smaller bias. Given the longitudinal setting in our study that
leads to a much larger number of parameters and therefore larger uncertainty in the off-diagonal elements
of V̂ , we use CW shrinkage in all our subsequent development.
3. Extension to time-varying exposures
In Section 2, we have considered only time-independent exposures. Here, we present the extension of
our method to time-varying exposures while all other notations remain the same. For subject i at time
tij, let Eij denote a p × 1 vector of observed exposure measurements and Uij be an m × 1 vector of latent
exposures. Then, models (1) and (2) can be rewritten as
Eij = 𝜈0 + 𝜈1jGi + Λ0Uij + Λ1jGi ⋅ Uij + 𝛿ij (1a)
and
Uij = 𝛼0 + 𝛼1jGi + 𝛼VVi + 𝜍ij. (2a)
Note that the regression coefficients unrelated to G are the same as those in (1) and (2) as we assume
the relationship between the observed exposure measurements and the underlying latent exposures for the
reference genetic subgroup (G = 0) is constant over time. Meanwhile, by allowing coefficients 𝜈1j, Λ1j,
and 𝛼1j related toG to vary over time, we incorporate the possibility of the time-varying G-E association,
that is, varying effect of genetic factors on exposure biomarkers over time. With age, different exposures
may bemetabolized differently inducing such time-varyingG-E association [18]. The error vectors 𝛿ij and
𝜍ij both have mean zero, and their variances can be either time-independent (ΘG andΦG, respectively) as
in (1) and (2) or time-varying (ΘG,j andΦGj, respectively) depending on the application context. However,
with moderate sample size, we may have to build more parsimonious models. For example, we may
constrain 𝜈1j = 𝜈1, Λ1j = Λ1, 𝛼1j = 𝛼1, ΘG,j = ΘG or ΦGj = ΦG. In this way, we are averaging the G-E
association over time.
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Given time-varying exposures, the outcome model can be modified as
Yij = 𝛽G,jGi + 𝛽U,jUij + 𝛽G×U,jGi ⋅ Uij + B∗0i +
∑
k
B∗ki fk(tij) + 𝜀ij, (3a)
where B∗0i = 𝛽0,0 + 𝛽
′
Z,0Zi + b0i (4a) and B
∗
ki = 𝛽0,k + 𝛽
′
Z,kZi + bki (5a). Note that in contrast to (3)–(5),
we separate the G and U terms from the functional terms involved in the temporal growth trajectory and
allow separate regression coefficients corresponding to G and U terms to vary over time. We can also
assume that 𝛽G,j, 𝛽U,j, and 𝛽G×U,j follow some specific parametric function of time. For example, if we
believe that there is a linear trend ofG×E effect over time, we would model 𝛽G×U,j to be a linear function
of time. Notations of parameters of covariates and variance components remain unchanged.
4. Example: weight growth prenatal lead exposure and the HFE gene
We used pooled data from ELEMENT, including three sequentially enrolled longitudinal birth cohorts
recruited between 1994 and 2005 at maternity hospitals serving low-income to moderate-income popula-
tions in Mexico City [1]. We focused our analysis on children’s weight as the health outcome, which was
measured longitudinally from birth to 48 months. Prenatal lead exposure is the main exposure of interest,
which has been demonstrated to have deleterious effects on birth weight [42] and weight trajectories [1].
Prenatal lead exposure biomarkers were collected on the mother and child, including lead concentrations
in umbilical cord blood and maternal blood at delivery, and maternal bone lead concentrations at two
bone sites (patella and tibia) [1, 42]. Among these four biomarkers, patella lead concentration is viewed
as a better indicator of cumulative fetal exposure for two reasons: (i) bone lead biomarkers are more
indicative of cumulative fetal exposure during pregnancy because blood lead primarily reflects the last
three months of exposure due to its relatively shorter half-life and (ii) patella is preferred over tibia bone
lead concentration because trabecular bone, such as the patella bone, has a faster turnover compared with
cortical bone (such as tibia), and thus more closely reflects exposure to the fetus during pregnancy [43].
Two known SNPs, C282Y and H63D, on the HFE gene [41] were considered as effect modifiers of the
lead-growth association. Because of sparsity of data, we applied dominant models for genetic suscepti-
bility and created a single indicator variable: zero for wild type on both SNPs and one for at least one
copy of either of the risk alleles. Although the HFE gene has been primarily linked with iron metabolism
[41], it has also been shown to modify lead absorption in an age-dependent fashion [8, 44]. As such, it
is possible that the correlations among exposure biomarkers may differ between wild types and variants,
implying that the exposure model coefficients may differ by genetic subgroup. The HFE gene has also
been shown to have joint health effects with lead exposure [6, 44].
To be included in this analysis, children must be genotyped, have weight measured at more than two
time points, and have at least one of the four prenatal exposures biomarkers (N = 758). We focused our
analysis on time points at birth and months 4, 12, 18, 24, 30, 36, and 48 when the cohorts had over 60%
complete weight measurements. We followed Afeiche et al. [1] in choosing additional covariates based
on biological relevance. Missing data on covariates was imputed five times [45], and parameter estimates
from each imputed dataset were combined by standard formulae [46].
The procedure to conduct our analysis can be summarized into the following steps:
(1) We defined an LV for prenatal lead exposure using the four lead biomarkers (Figure 1). Because
patella lead is a preferred biomarker of cumulative lead exposure during pregnancy as mentioned
before, the mean and scale of the LV are set equal to those of patella lead using the identifiability
constraints described in Section 2.1.
(2) We modeled the weight growth trajectories by regressing weight on time in the linear mixed model
adjusting for selected covariates. We did not consider the genetic factor or lead exposures at this
stage. We incorporated functions of t, t2, and log(t) (hence, K = 3) in the model to capture the time
trend of the mean weight trajectory, which have been typically used to model growth trajectories in
children [37]. We further examined the model fit with residual plots.
(3) We fit the overall G × E model to the data to examine the marginal G × E effect averaged over the
whole study period.
(4) Given the balanced design with respect to time (except for missed visits), we explored the G × E
effect for each time point by treating time as dummy variables, denoted as the ‘discrete time G×E
1234
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model’. Specifically, for subject i with genetic category Gi at time j (i = 1,… , 758 and j = 1,… , 8
in our example),
Yij = 𝛾G,jGi + 𝛾U,jUi + 𝛾G×U,jGi ⋅ Ui + 𝛾
′
j Xij + eij (7)
where 𝛾G,j, 𝛾U,j and 𝛾G×U,j are regression coefficients for genetic factor Gi latent exposure Ui and
the interaction term, respectively, and Xij and 𝛾j are vectors of covariates (including intercept) and
regression coefficients, respectively. The error vector e
′
i = (ei1,… , ei8) ∼ N(0,Σ8×8), where Σ8×8
was unstructured in our analysis, based on model fit. By plotting 𝛾G×U,j against tj, we found that
although the outcome model included multiple fk(t)’s (i.e., t, t2 and log(t)), theG×U×T term could
be described with a simple linear function of time h(t) = t, a subset of fk(t)’s. In other applications,
it is possible that h(t) is completely different from fk(t)’s.
(5) We fit the G × E × T model to the data by forcing the coefficients of G ×U terms corresponding to
t2 and log(t) to be zero while retaining all other terms, including the G × U term for t, in (5).
Results from the ELEMENT analysis
The weight data at birth is complete while at other ages, the percent of missingness ranges from 12.5% to
36.7% (Supplemental Materials, Table S1). The weight increases over time but with decreasing rate, and
the variance is increasing (Figure 2). By applying the overall G × E model, we do not find a significant
overall G×E effect (Table II). However, there is a decreasing trend in G×E effect over time when fitting
the discrete time G × E model and plotting 𝛽G×U against time (aforementioned step 3, Figure 3). The
negative 𝛽G×U indicates that carrying a variant for the HFE gene may exacerbate the deleterious effects
of prenatal lead exposures on weight growth, particularly after one year from birth. The decreasing trend
indicates that the degree of exacerbation may escalate over time. Comparing the results from the overall
G × E model and discrete time G × E model, it is clear that if we ignore the time-varying component in
the G × E effect, we would completely miss the G × E signal.
Guided by the discrete time G × E model, we fitted the G × E × T model with linear T (Table II).
We found a statistically significant 𝛽G×U×T , indicating that the modification of lead-growth association
by HFE status is age-dependent. The estimates and robust standard errors under AI are fairly similar to
those under AD, likely implying weakG-E andG-b associations. The negative estimates indicate that, on
average, the variants compared with wild types may suffer from even further reductions in weight gain in
association with higher lead exposure (i.e., further impairment in growth). Via shrinkage estimation, the
further reduction in weight gain associated with 10μgPb/g higher patella bone concentration is estimated
to increase by 96.9 g every 6 months. In other words, comparing two children that only differ in HFE
status, if their patella lead level were both to increase by 10μgPb/g, the one in the variant group would
gain less weight than the one in the wild-type group, and their difference in weight gain would increase
by 96.9 g every 6 months. Using appropriate linear combinations of 𝛽G×U and 𝛽G×U×T , we also calculated
estimates for the G × E association at each age as shown in Figure 3. Compared with the discrete time
G × E model, the estimates from the G × E × T model are generally similar, while the standard errors
Figure 2. Scatterplot of children?s weight (kg) by age (months) in the ELEMENT example.
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Table II. Parameter estimates and robust standard errors obtained using
MLE derived assuming AI and AD, and shrinkage estimates (SK) for
ELEMENT data.
Estimation
Overall G × E model G × E × T model with linear Ta
method 𝛽U 𝛽G×U 𝛽G×U 𝛽G×U×T
AI 15.2 (27.2) −25.1 (45.1) −20.7 (43.7) −96.6 (43.4)∗
AD 17.3 (29.6) −21.6 (47.8) −16.7 (46.6) −97.1 (45.5)∗
SK 15.5 (27.4) −24.4 (45.5) −18.0 (45.0) −96.9 (43.9)∗
Given the identifiability constrains on the exposure model, coefficients represent
changes in weight (g) associated with 10μgPb/g higher patella lead level. Models
are adjusted for maternal age, height, calf circumference, parity, education, marital
status, lifestyle, and calcium treatment, as well as children’s gestational age, cohort,
and repeated measures of height.
aT has been rescaled to represent changes per 6 months.
∗p-value < 0.05.
Figure 3. Shrinkage estimates and 95% confidence interval for gene–environmental interaction over time, repre-
senting the difference in the lead-weight association in HFE gene variants compared with wild types at each age.
The black circles are from the analysis with the discrete time G×E model and the empty circles are from analysis
with the G × E × T model linear in T . The dashed line indicates null effect.
are much smaller, resulting in improved power. This example illustrates the value of thinking about time-
dependent features in interaction patterns as opposed to an interaction term that is assumed to be constant
over time.
5. Simulation studies
We carried out simulation studies to assess the bias, efficiency, MSE, power, and Type-I error properties
of our methods. Specifically, we considered three settings of simulations where the true models are as
follows: (i) the null model of no G × E effect at any time point; (ii) time-independent G × E effect; and
(iii) time-varying G × E effect.
5.1. Simulations with time-invariant exposures
We used a sample size of N = 500 that is typical in environmental health studies. The genetic subgroup
was generated as a binary variable with prevalence 0.3: zero for all wild types and one for having at
least one variant. We simulated four exposure measurements, assuming that they measured one latent
exposure. The latent exposure, under AD, was simulated from N(0, 1) for the wild type group and N(1,
2) for the variant group (i.e., 𝛼1 = 1, Φ = 1, and Φ1 = 2 in (2)), while under AI, N(0, 1) for both
groups. The latent outcomes were generated as random intercept and random slope for each subject
(K = 1 and f (t) = t in (3)). The longitudinal outcomes were generated at five equally spaced time
points (t = 0, …, 4).
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Our parameters of interest are 𝛽G×U , the baseline difference in exposure effect between genetic sub-
groups, and 𝛽G×U×T , the difference in the G × E effect by unit increase of time. The true interaction
parameters for the three settings were (i) 𝛽G×U = 𝛽G×U×T = 0; (ii) 𝛽G×U = 2, 𝛽G×U×T = 0; and (iii) 𝛽G×U =
2, 𝛽G×U×T = −1 with the G × U × T term assumed to be linear in T , respectively. For all three settings,
we investigated the properties of our estimators when the underlying data generating mechanism was AI
or AD. For setting 3, we further considered two scenarios: (i) data was simulated under G-E indepen-
dence and G-b heteroscedasticity, denoted as ‘APD1’, to isolate the role of G-b heteroscedasticity alone
in determining the operating characteristics of the methods and (ii) data were simulated under G-E par-
tial dependence (only a subset of exposures interactive with genes) and G-b homoscedasticity, denoted
as ‘APD2’. Details regarding the choice of remaining parameters and how they varied across genetic sub-
groups can be found in the Supplemental Materials, Table S3. For settings 1 and 2, we fitted the overall
G × E model, and for setting 3, we also fitted the G × E × T model. We summarized the results based
on 500 replicated datasets.
Simulation results
Table III presents the estimates from the overall G × E model for all three settings. When there is no
interaction in the true model (𝛽G×U = 𝛽G×U×T = 0) and the data are generated under AI, all methods
have acceptable biases and Type-I error rates. However, when the data are generated under AD, only the
MLE assuming AD and the SK retain probability of rejection of a null hypothesis (P(R)) close to 0.05
at the nominal level of 0.05. As expected, MLE assuming AI has bias and inflated Type-I error in this
scenario. When the overall G × E effect exists (𝛽G×U = 2 and 𝛽G×U×T = 0), all approaches have power
of at least 0.75 except MLE assuming AI with data generated under AD. This loss of power is primarily
due to severe bias in 𝛽G×U(−36.0%). In the first two settings, the SK performs very similar to the correct
estimator, in terms of bias, MSE, and power (P(R)). For setting 3 (𝛽G×U = 2 and 𝛽G×U×T = −1) when the
overall G × E model is misspecified, none of these approaches have adequate performance.
Table IV presents the results from fitting the model with linear G × U × T term to the data generated
in setting 3. Under data scenario AI or APD1, all approaches have satisfactory performance with the
correct approach being the most unbiased and efficient. However, under data scenario AD or APD2,
MLE assuming AI is seriously biased for both 𝛽G×U and 𝛽G×U×T . The similarities between scenarios AI
and APD1 and between AD and APD2 indicate that G-E dependence may be more critical than G-b
heteroscedasticity for determining the performances of our methods. For each of the four scenarios, the
SK maintains very acceptable bias and efficiency
5.2. Simulations with time-varying exposures
We also conducted simulations assuming exposures are measured concurrently with the outcome, as
postulated in (1a)–(2a). Again, we generated outcomes and exposures at five time points. We simulated
Table III. Bias (or percent bias), MSE, and rejection probabilities (P(R)) for estimates of time-





scenario methoda Bias MSE P(R) Bias% MSE P(R) Bias% MSE P(R)
AI AIc 0.00 0.33 0.04 1.2 0.35 0.93 −47.5 1.24 0.42
ADc 0.03 0.38 0.05 3.0 0.47 0.90 −38.3 1.08 0.37
SKd 0.02 0.36 0.04 1.4 0.41 0.92 −42.5 1.14 0.41
AD AIc −0.53 0.68 0.19 −36.0 0.92 0.62 −72.0 2.20 0.19
ADc 0.01 0.48 0.05 1.1 0.69 0.80 −15.1 1.85 0.52
SKd −0.11 0.47 0.08 −7.1 0.68 0.75 −23.3 1.59 0.40
aEstimation uses the model with only time-independent G × U term.
b(1) 𝛽G×U = 𝛽G×U×T = 0; (2) 𝛽G×U = 2, 𝛽G×U×T = 0; and (3) 𝛽G×U = 2, 𝛽G×U×T = −1. f (t) = t for all three
settings.
cMLE derived assuming AI or AD.
dShrinkage estimator combining AI and AD.
Copyright © 2014 John Wiley & Sons, Ltd. Statist. Med. 2015, 34 1227–1241
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Table IV. Percent bias, variance ratios (Var.R), MSE, and rejection probabilities (P(R)) for
estimates of G × E effect with data simulated under AI, AD APD1, and APD2a.
Data Estimation
𝛽G×U 𝛽G×U×T
scenario methodb Bias% Var.R MSE P(R) Bias% Var.R MSE P(R)
AI AIc 0.5 1(Ref) 0.43 0.82 −2.3 1(Ref) 0.11 0.79
ADc 2.4 (1.16) 0.50 0.82 −3.8 (1.04) 0.12 0.73
SKd 1.2 (1.07) 0.45 0.81 −3.0 (1.02) 0.11 0.75
AD AIc −26.2 1(Ref) 0.85 0.66 −18.9 1(Ref) 0.16 0.90
ADc 2.0 (1.32) 0.75 0.77 2.1 (1.03) 0.13 0.86
SKd −6.8 (1.22) 0.71 0.72 −6.6 (1.1) 0.12 0.89
APD1 AIc 5.5 1(Ref) 0.48 0.86 −12.3 1(Ref) 0.18 0.63
ADc 2.8 (1.13) 0.53 0.80 −4.5 (1.01) 0.15 0.64
SKd 3.0 (1.06) 0.50 0.82 −6.3 (1.00) 0.16 0.64
APD1c 1.1 (0.97) 0.45 0.82 −4.0 (0.96) 0.14 0.69
APD2 AIc −24.6 1(Ref) 0.73 0.71 −18.2 1(Ref) 0.15 0.86
ADc 1.0 (1.17) 0.57 0.84 −2.7 (1.07) 0.13 0.89
SKd 5.3 (1.16) 0.58 0.78 −6.7 (1.01) 0.13 0.88
APD2c 0.9 (1.01) 0.51 0.85 −2.5 (0.98) 0.11 0.90
𝛽G×U = 2, 𝛽G×U×T = −1, f (t) = t, and sample size N = 500, with 500 replicates.
aAPD1: G-E independence and G-b heteroscedasticity; APD2: G-E partial dependence and G-b
homoscedasticity.
bEstimation uses the model with both linear G × U and G × U × T terms.
cMLE derived assuming AI, AD, APD1 or APD2
dShrinkage estimator combining AI and AD.
Table V. Bias (or percent bias), variance ratios (Var.R), MSE, and rejection probabilities (P(R)) for




setting methoda Bias Var.R MSE P(R) Bias Var.R MSE P(R)
𝛽G×U = Trueb 0.01 1(Ref) 0.29 0.03 0.00 1(Ref) 0.16 0.03
𝛽G×U×T = AIc −0.09 (1.02) 0.31 0.05 −0.22 (0.98) 0.28 0.09
0 AD1c 0.03 (1.12) 0.33 0.04 0.02 (1.10) 0.21 0.04
AD2c 0.11 (1.03) 0.30 0.05 −0.10 (1.03) 0.20 0.05
SK1d −0.03 (1.06) 0.31 0.04 −0.03 (1.18) 0.22 0.05
SK2d −0.02 (1.03) 0.30 0.05 −0.12 (1.01) 0.21 0.07
𝛽G×U = 2 Trueb 0.5% 1(Ref) 0.32 0.90 −1.6% 1(Ref) 0.21 0.69
𝛽G×U×T = − AIc −9.5% (1.01) 0.38 0.89 −32.2% (0.98) 0.35 0.76
1 AD1c −2.0% (1.21) 0.40 0.87 1.2% (1.16) 0.26 0.60
AD2c 2.9% (1.08) 0.35 0.92 −16.7% (1.01) 0.28 0.72
SK1d −3.1% (1.16) 0.39 0.87 −3.9% (1.12) 0.28 0.67
SK2d 0.9% (1.06) 0.34 0.90 −20.1% (1.01) 0.30 0.73
Sample size N = 500 with 500 replicates.
aEstimation uses the model with both linear G × U and G × U × T terms.
bModel with true G-E association: AI for time 1 and 2, and AD for time 3, 4, and 5.
cMLE derived assuming AI, AD with time-varying G-E association (AD1), or AD with time-independent
G-E association (AD2).
dShrinkage estimator combining AI and AD1 (SK1), or AI and AD2 (SK2).
exposures for each time point separately and also incorporated time-varying G-E association in the true
model: AI for time points 1 and 2 and AD for time points 3, 4, and 5 (details on parameter setting can
be found in the Supplemental Materials, Table S3). We set G-b heteroscedasticity for all time points. We
considered two situations where there was no G × E effect (𝛽G×U = 𝛽G×U×T = 0) or there was time-
varying G × E effect (𝛽G×U = 2 and 𝛽G×U×T = −1). Then, we applied two types of AD models: one with
time-varying G-E association (AD1) and the other with time-independent G-E association (AD2). We
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also calculated MLE assuming AI and used shrinkage estimation to combine AD1 with AI, denoted as
SK1, as well as AD2 with AI, denoted as SK2. As a comparison benchmark, we analyzed the data with
the correct G-E and G-b association (only possible in a simulation study where we know the truth).
Simulation results
Under the setting with no G × E effect, we find that all the methods have P(R) (Type-I error) close to
0.05 at the significance level of 0.05 (Table V). However, MLE assuming AI, as a parsimonious method
with the most restricted set of assumptions, leads to large bias for 𝛽G×U×T . MLE assuming AD2 also has
some bias due to misspecification of the G-E association. When there is time-varying G × E effect, we
find different results for 𝛽G×U and 𝛽G×U×T . Despite some bias from MLE assuming AI, all other methods
show satisfactory performance for 𝛽G×U . In contrast, the power for 𝛽G×U×T is lower (0.60–0.76). MLEs
assuming AI and AD2 yield biased estimates, while MLE assuming AD1 has much less bias but also
reduced power, likely due to the large number of parameters (124 for AD1 versus 83 for correct model).
SK1 has relatively acceptable performance in bias and power, when compared with SK2 and the correct
method, which indicates that when dealing with time-varying exposures with possible time-varying G-E
association, we need to include the more flexible model as a component for shrinkage estimation in order
to control bias.
6. Discussion
The current study, as an extension of the cross-sectional outcome work by Sánchez et al. [26], has multi-
ple strengths. It further shows the advantages of using LV models to reduce dimensionality of correlated
exposure variables and longitudinal outcome. It limits the number of tests to be conducted and boosts
power by using a single integrated model. It also has a cohesive interpretation if the existence of LV
is natural, as is the case for blood and bone lead biomarkers in our example. Furthermore, it takes into
account the possibility of mutual dependence between gene, exposures, and outcome. By using shrinkage
estimation, we avoid testing each assumption separately and still obtain estimates that retain good oper-
ating characteristics. The most important contribution is to posit a framework that allows time-varying
interaction and time-varying association. When the G-E dependence varies over time, a shrinkage factor
that accounts for heterogeneity of the G-E association is needed.
Further extensions to accommodate semi-parametric or non-parametric smoothing terms instead of the
highly parametric longitudinal model we have considered seem a natural continuation of our work. The
normality assumption on the random effects and errors can also be relaxed to incorporate non-normal
data. Moreover, the outcome can be multivariate longitudinal [47], and one may add another layer of
measurement models for the outcome at each time point.
It is also important to consider how to define genetic subgroups to meaningfully stratify on genetic
risk for a given outcome–exposure association. For the methods presented, genetic strata need to be
determined a priori, for example, through the quantiles of a combined risk index from a pathway or a
gene region. In ELEMENT, a very interesting question is how to model the mother-child pair of genes
together [6]. However, the limited sample size will always be an issue if one is trying to have multiple
genetic subgroups. Whether an LV model can help reduce dimensionality of a correlated gene space is
also something to be explored in future studies.
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